Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.94 AUD | +0.93% | +5.85% | +2.05% |
Apr. 25 | Newcore Gold Details Updated Preliminary Economic Assessment for Enchi Gold Project in Ghana | MT |
Apr. 15 | Lycopodium Secures AU$30 Million Construction Contract | MT |
Valuation
Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 184.8 | 192.3 | 189.1 | 214.6 | 226.5 | 420.5 |
Enterprise Value (EV) 1 | 111.7 | 132.6 | 89.9 | 155.7 | 142.2 | 353.7 |
P/E ratio | 10.2 x | 11.7 x | 16.1 x | 15.2 x | 8.33 x | 8.99 x |
Yield | 6.45% | 6.2% | 4.2% | 4.63% | 9.47% | 7.66% |
Capitalization / Revenue | 0.95 x | 1.26 x | 0.9 x | 1.35 x | 0.99 x | 1.3 x |
EV / Revenue | 0.57 x | 0.87 x | 0.43 x | 0.98 x | 0.62 x | 1.09 x |
EV / EBITDA | 4.23 x | 14.7 x | 5.95 x | 5.05 x | 4.82 x | 5.32 x |
EV / FCF | 1,102 x | -9.07 x | 1.47 x | -11.2 x | 3.58 x | 77.4 x |
FCF Yield | 0.09% | -11% | 68.1% | -8.89% | 27.9% | 1.29% |
Price to Book | 2.42 x | 2.41 x | 2.41 x | 2.43 x | 2.25 x | 3.67 x |
Nbr of stocks (in thousands) | 39,732 | 39,732 | 39,732 | 39,740 | 39,740 | 39,740 |
Reference price 2 | 4.650 | 4.840 | 4.760 | 5.400 | 5.700 | 10.58 |
Announcement Date | 9/21/18 | 9/30/19 | 8/26/20 | 8/24/21 | 8/23/22 | 8/21/23 |
Income Statement Evolution (Annual data)
Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 194.6 | 152.2 | 209.6 | 159.1 | 228.7 | 323.9 |
EBITDA 1 | 26.44 | 9.036 | 15.1 | 30.8 | 29.53 | 66.52 |
EBIT 1 | 25.4 | 7.785 | 13.95 | 29.66 | 27.81 | 64.16 |
Operating Margin | 13.05% | 5.11% | 6.66% | 18.64% | 12.16% | 19.81% |
Earnings before Tax (EBT) 1 | 25.29 | 23.54 | 18.45 | 21.49 | 38.93 | 63.28 |
Net income 1 | 18.17 | 16.51 | 11.8 | 14.2 | 27.18 | 46.78 |
Net margin | 9.34% | 10.84% | 5.63% | 8.93% | 11.88% | 14.44% |
EPS 2 | 0.4570 | 0.4150 | 0.2960 | 0.3550 | 0.6839 | 1.177 |
Free Cash Flow 1 | 0.1014 | -14.62 | 61.25 | -13.85 | 39.75 | 4.568 |
FCF margin | 0.05% | -9.6% | 29.22% | -8.7% | 17.38% | 1.41% |
FCF Conversion (EBITDA) | 0.38% | - | 405.56% | - | 134.61% | 6.87% |
FCF Conversion (Net income) | 0.56% | - | 518.93% | - | 146.25% | 9.76% |
Dividend per Share 2 | 0.3000 | 0.3000 | 0.2000 | 0.2500 | 0.5400 | 0.8100 |
Announcement Date | 9/21/18 | 9/30/19 | 8/26/20 | 8/24/21 | 8/23/22 | 8/21/23 |
Income Statement Evolution (Quarterly data)
Fiscal Period: June | 2021 S1 | 2021 S2 | 2022 S1 |
---|---|---|---|
Net sales | - | 91.13 | - |
EBITDA | - | 15.96 | - |
EBIT | - | 13.61 | - |
Operating Margin | - | 14.93% | - |
Earnings before Tax (EBT) | - | 13.41 | - |
Net income 1 | 6.32 | 7.88 | 15.26 |
Net margin | - | 8.65% | - |
EPS 2 | 0.1530 | - | 0.3810 |
Dividend per Share | - | - | - |
Announcement Date | 2/23/21 | 8/24/21 | 2/22/22 |
Balance Sheet Analysis
Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 73 | 59.7 | 99.2 | 58.9 | 84.3 | 66.7 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | 0.1 | -14.6 | 61.3 | -13.8 | 39.7 | 4.57 |
ROE (net income / shareholders' equity) | 24.7% | 20.7% | 14.9% | 17% | 28.7% | 42.9% |
ROA (Net income/ Total Assets) | 11.3% | 3.72% | 6.33% | 11.6% | 9.08% | 18.4% |
Assets 1 | 161.5 | 443.2 | 186.5 | 122.5 | 299.4 | 253.6 |
Book Value Per Share 2 | 1.920 | 2.010 | 1.980 | 2.220 | 2.530 | 2.880 |
Cash Flow per Share 2 | 1.870 | 1.520 | 2.590 | 1.930 | 2.540 | 2.070 |
Capex 1 | 1.05 | 1.61 | 0.47 | 2.67 | 3.95 | 4.35 |
Capex / Sales | 0.54% | 1.05% | 0.23% | 1.68% | 1.73% | 1.34% |
Announcement Date | 9/21/18 | 9/30/19 | 8/26/20 | 8/24/21 | 8/23/22 | 8/21/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+2.05% | 309M | |
-2.29% | 67.67B | |
+2.13% | 59.37B | |
+21.25% | 38.3B | |
+11.23% | 30.73B | |
+2.06% | 26.35B | |
+22.89% | 22.01B | |
+15.06% | 19.47B | |
+22.99% | 17.6B | |
+64.33% | 16.64B |
- Stock Market
- Equities
- LYL Stock
- Financials Lycopodium Limited